Cargando…
GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
AIMS/HYPOTHESIS: Oestrogens have previously been shown to exert beta cell protective, glucose-lowering effects in mouse models. Therefore, the recent development of a glucagon-like peptide-1 (GLP-1)–oestrogen conjugate, which targets oestrogen into cells expressing GLP-1 receptors, offers an opportu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320309/ https://www.ncbi.nlm.nih.gov/pubmed/25527001 http://dx.doi.org/10.1007/s00125-014-3478-3 |
_version_ | 1782356103969898496 |
---|---|
author | Schwenk, Robert W. Baumeier, Christian Finan, Brian Kluth, Oliver Brauer, Christine Joost, Hans-Georg DiMarchi, Richard D. Tschöp, Matthias H. Schürmann, Annette |
author_facet | Schwenk, Robert W. Baumeier, Christian Finan, Brian Kluth, Oliver Brauer, Christine Joost, Hans-Georg DiMarchi, Richard D. Tschöp, Matthias H. Schürmann, Annette |
author_sort | Schwenk, Robert W. |
collection | PubMed |
description | AIMS/HYPOTHESIS: Oestrogens have previously been shown to exert beta cell protective, glucose-lowering effects in mouse models. Therefore, the recent development of a glucagon-like peptide-1 (GLP-1)–oestrogen conjugate, which targets oestrogen into cells expressing GLP-1 receptors, offers an opportunity for a cell-specific and enhanced beta cell protection by oestrogen. The purpose of this study was to compare the effects of GLP-1 and GLP-1–oestrogen during beta cell failure under glucolipotoxic conditions. METHODS: Male New Zealand obese (NZO) mice were treated with daily s.c. injections of GLP-1 and GLP-1–oestrogen, respectively. Subsequently, the effects on energy homeostasis and beta cell integrity were measured. In order to clarify the targeting of GLP-1–oestrogen, transcription analyses of oestrogen-responsive genes in distinct tissues as well as microarray analyses in pancreatic islets were performed. RESULTS: In contrast to GLP-1, GLP-1–oestrogen significantly decreased food intake resulting in a substantial weight reduction, preserved normoglycaemia, increased glucose tolerance and enhanced beta cell protection. Analysis of hypothalamic mRNA profiles revealed elevated expression of Pomc and Leprb. In livers from GLP-1–oestrogen-treated mice, expression of lipogenic genes was attenuated and hepatic triacylglycerol levels were decreased. In pancreatic islets, GLP-1–oestrogen altered the mRNA expression to a pattern that was similar to that of diabetes-resistant NZO females. However, conventional oestrogen-responsive genes were not different, indicating rather indirect protection of pancreatic beta cells. CONCLUSIONS/INTERPRETATION: GLP-1–oestrogen efficiently protects NZO mice against carbohydrate-induced beta cell failure by attenuation of hyperphagia. In this regard, targeted delivery of oestrogen to the hypothalamus by far exceeds the anorexigenic capacity of GLP-1 alone. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-014-3478-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-4320309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-43203092015-02-11 GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice Schwenk, Robert W. Baumeier, Christian Finan, Brian Kluth, Oliver Brauer, Christine Joost, Hans-Georg DiMarchi, Richard D. Tschöp, Matthias H. Schürmann, Annette Diabetologia Article AIMS/HYPOTHESIS: Oestrogens have previously been shown to exert beta cell protective, glucose-lowering effects in mouse models. Therefore, the recent development of a glucagon-like peptide-1 (GLP-1)–oestrogen conjugate, which targets oestrogen into cells expressing GLP-1 receptors, offers an opportunity for a cell-specific and enhanced beta cell protection by oestrogen. The purpose of this study was to compare the effects of GLP-1 and GLP-1–oestrogen during beta cell failure under glucolipotoxic conditions. METHODS: Male New Zealand obese (NZO) mice were treated with daily s.c. injections of GLP-1 and GLP-1–oestrogen, respectively. Subsequently, the effects on energy homeostasis and beta cell integrity were measured. In order to clarify the targeting of GLP-1–oestrogen, transcription analyses of oestrogen-responsive genes in distinct tissues as well as microarray analyses in pancreatic islets were performed. RESULTS: In contrast to GLP-1, GLP-1–oestrogen significantly decreased food intake resulting in a substantial weight reduction, preserved normoglycaemia, increased glucose tolerance and enhanced beta cell protection. Analysis of hypothalamic mRNA profiles revealed elevated expression of Pomc and Leprb. In livers from GLP-1–oestrogen-treated mice, expression of lipogenic genes was attenuated and hepatic triacylglycerol levels were decreased. In pancreatic islets, GLP-1–oestrogen altered the mRNA expression to a pattern that was similar to that of diabetes-resistant NZO females. However, conventional oestrogen-responsive genes were not different, indicating rather indirect protection of pancreatic beta cells. CONCLUSIONS/INTERPRETATION: GLP-1–oestrogen efficiently protects NZO mice against carbohydrate-induced beta cell failure by attenuation of hyperphagia. In this regard, targeted delivery of oestrogen to the hypothalamus by far exceeds the anorexigenic capacity of GLP-1 alone. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-014-3478-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2014-12-20 2015 /pmc/articles/PMC4320309/ /pubmed/25527001 http://dx.doi.org/10.1007/s00125-014-3478-3 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Article Schwenk, Robert W. Baumeier, Christian Finan, Brian Kluth, Oliver Brauer, Christine Joost, Hans-Georg DiMarchi, Richard D. Tschöp, Matthias H. Schürmann, Annette GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice |
title | GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice |
title_full | GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice |
title_fullStr | GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice |
title_full_unstemmed | GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice |
title_short | GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice |
title_sort | glp-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone new zealand obese (nzo) mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320309/ https://www.ncbi.nlm.nih.gov/pubmed/25527001 http://dx.doi.org/10.1007/s00125-014-3478-3 |
work_keys_str_mv | AT schwenkrobertw glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT baumeierchristian glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT finanbrian glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT klutholiver glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT brauerchristine glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT joosthansgeorg glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT dimarchirichardd glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT tschopmatthiash glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice AT schurmannannette glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice |